EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

MONITORING OF CD4 IN HIV PATIENTS PRE AND POST TREATMENT WITH ANTIRETROVIRAL THERAPY (ART)

Mohammed Amood AL-Kamarany*, Ahmed Mahyoub, Entibah AL-Hamadi, Husain Faqirah, Tarik Abdulkarim

ABSTRACT

Background: Human Immunodeficiency Virus (HIV) infection leads to a progressive reduction in the number of T cells expressing CD4. World Health Organization (WHO) recommends antiretroviral therapy (ART) for all people with HIV. Also WHO recommends to monitor the CD4 as indication of treatment failure and the need to switch from first-line to second-line drugs. Objectives: Therefore, the study aims to monitor the efficacy of ART in HIV patients hospitalizations based on CD4 count using protocol of National AIDS and HIV Control Program that is derived from World Health Organization (WHO) guideline. Methods: Based on a cross sectional study, 15 subjects were collected from adults of 27–52 years of age, suffering from diarrhea, recurrent oral ulceration, fungal infection, lymphadenopathy, herpes zoster and fever attended at the center of tropical medicine and infectious diseases (CTMID) of Authority of Public AL- Thawra Hospital in Hodeidah, Yemen. HIV was diagnosed clinically and laboratory namely HIV antigen test, then CD4 count was assayed pre – treatment. The treatment course consists of triple ART namely Tenofovir /Efavirenz / Emtricitabine. The efficacy of ART was monitored based on CD4 count post six months. Results: 15 patients were enrolled in unit of HIV treatment and monitored pre and post treatment. The average of CD4 count pre - treatment was 216 ± 129 cell/μL and increased post – treatment about 404 ± 236 cell/μL. The patients improved , that was significantly statistically different (p < 0.05) between pre and post – treatment . Conclusion: The finding data showed that the ART improved the immunity and the quality of life for HIV patients.

Keywords: ART, HIV, Monitoring, CD4, Efficacy, Therapeutic, Yemen.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 December 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: DECEMBER ISSUE PUBLISHED

    DECEMBER Issue has been successfully launched on 1 December 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )